NCT05025462View on ClinicalTrials.gov

Salmon Peptide Fraction: Safety and Cardiometabolic Health

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

July 26, 2023

Study Completion Date

July 26, 2023

Conditions
Metabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Supplement dose 15g/d

Supplementation with 15g/day of SPF or Comparator

DIETARY_SUPPLEMENT

Supplement dose 7.5g/d

Supplementation with 7.5g/d of SPF ou comparator

Trial Locations (1)

G1V 0A6

INAF, Université Laval, Québec

All Listed Sponsors
lead

Laval University

OTHER

NCT05025462 - Salmon Peptide Fraction: Safety and Cardiometabolic Health | Biotech Hunter | Biotech Hunter